Kringle Pharma Inc.
Basic information
- Head office
- 4-3-51 Nakanoshima Qross, 10th Floor, Future Medical R&D Center, Nakanoshima, Kita-ku, Osaka, 530-0005, Japan
- Chief executive
- Kiyohiro Adachi
- Capital
- 64,000,000
- Employees (non-consolidated)
- 17 people
- Employees (consolidated)
- 17 people
- Start date
- 2001-12-21
- End date
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
Network
History
Established Clingul Pharma Co., Ltd. as a drug discovery bio‑venture originating from Osaka University and Keio University.![]()
Obtained development rights for HGF protein from the late Professor Toshio Nakamura (Professor Emeritus, Osaka University) and commenced development (development code: KP-100).![]()
Established a manufacturing method for large-scale production of HGF protein active ingredient (pharmaceutical grade).![]()
Completed a Phase Ib clinical trial of HGF protein in patients with renal failure in the United States.![]()
Completed a Phase I/II clinical trial (physician-led) of HGF protein in patients with vocal fold scarring in Japan.![]()
The Ministry of Health, Labour and Welfare designated HGF protein for acute spinal cord injury as a rare disease drug.![]()
Capital and business alliance with Toho Holdings Inc. to establish a wholesale distribution system for HGF drug targeting acute spinal cord injury.![]()
Capital and business alliance with Maruishi Pharmaceutical Co., Ltd. to build a sales system for KP-100IT targeting acute spinal cord injury.![]()
Signed a joint research agreement with Keio University School of Medicine to apply HGF therapy for spinal cord injury.![]()
Initiated a Phase I/II clinical trial targeting neurotrophic keratitis by Clarus BioTherapeutics Inc. in the United States.![]()
The international nonproprietary name for recombinant human HGF protein (KP-100) was designated as 'Oremepermin Alfa'.![]()
The international non‑proprietary name for recombinant human HGF protein (KP‑100) was decided as 'Oremepermin Alfa'.![]()
Co-filed a patent with Keio University School of Medicine on treatment for chronic spinal cord injury.![]()
Co-filed a patent with Keio University School of Medicine on combined HGF and iPS cell therapy for spinal cord injury.![]()
Started collaboration with Clarus Biotherapeutics in the U.S. to improve efficiency and scale of recombinant human HGF protein production.![]()
Completed the final observation day of the Phase III clinical trial targeting acute spinal cord injury.![]()
News
There is no news.
Public records
National Tax Agency basic information7120901027189
- Trade name
- クリングルファーマ株式会社
- Trade name (kana)
- クリングルファーマ
- Name in English
- Corporation type
- 301
- Address
- 〒530-0005 大阪府大阪市北区中之島4丁目3番51号
- Postal code
- 5300005
- Prefecture code
- 27
- City code
- 127
- Address outside Japan
- Prefecture in English
- City in English
- Address outside Japan in English
- Corporate number assignment date
- 2015-10-05
- Update date
- 2026-01-09
- Change date
- 2026-01-07
- Registry closure date
- Reason for registry closure
- Successor corporate number
- Details of the change
- Latest record
- 1
- Excluded from search
- 0
- Processing type
- 12
- Correction type
- 0
- Trade name image ID
- Address image ID
- Sequence number
- 4344786
METI gBizINFO7120901027189
- Corporate number
- 7120901027189
- Trade name
- クリングルファーマ株式会社
- Trade name (kana)
- クリングルファーマ
- Trade name (alphabet)
- Registry closure date
- Reason for registry closure
- Registered address
- 大阪府大阪市北区中之島4丁目3番51号
- Postal code
- 5300005
- Prefecture
- 大阪府
- Prefecture code
- 27
- City or district
- 大阪市北区
- City code
- 127
- Street address
- 中之島4丁目3番51号
- Organisation type
- 301
- Processing type
- 12
- Correction type
- 0
- Status
- Representative
- 代表取締役社長 安達 喜一
- Capital
- 64176000
- Employees
- 17
- Employees (male)
- Employees (female)
- Business summary
- HGFを医薬品とするための研究開発、製造、販売
- Website URL
- Year founded
- Business category
- E:製造業
- Date established
- Unified government qualification - grade
- Unified government qualification - business items
- Update date
- 2026-01-09
- Key information
- 7120901027189